More Articles

Patients and Medical

Digital patient engagement finalists revealed

Lucy Fisher, (Apr 9, 2024)

Finalists for Pharma Awards Europe 2024 have been announced for ‘Most Valuable Digital Patient Engagement’, sponsored by Sciensus.
Access and Evidence

Cell and gene therapy: how to discover and communicate clinical worth

Anonymous (not verified), (Mar 22, 2024)

CGTs are often expensive, and the healthcare sector is increasingly working on a tight budget. To bolster CGT market access potential, pharma companies should take a holistic approach.
Access and Evidence

What not to miss on Cell and Gene Therapy stage at Reuters Events: Pharma USA 2024

Lucy Fulford, (Mar 20, 2024)

From building a solid value proposition to innovating through collaboration, discover where industry changemakers see the strengths of cell and gene in 2024.

Cell and gene therapy: ways to generate evidence to demonstrate value

Anonymous (not verified), (Feb 23, 2024)

Although cell and gene therapies (CGTs) are typically expensive products, there are techniques that pharmaceutical companies can execute to underscore why they are worthwhile.

How pharma is empowering key account managers to serve a changing customer base

Nick Taylor, (Feb 7, 2024)

Key account management (KAM) has become increasingly important to pharma companies as payers and other stakeholders have begun to exert more influence over the products physicians prescribe

Diversity in clinical trials requires a multifaceted approach

Anonymous (not verified), (Feb 5, 2024)

Clinical trial sponsors should implement multiple approaches to boost diversity in studies, from ensuring collected data reflect participant diversity, to working with a diverse group of investigators
Patients and Medical

Three Pathways to Patient Centricity and Win-Win Stakeholder Outcomes  

Anonymous (not verified), (Feb 2, 2024)

A round up of a panel discussion at Reuters Events: Pharma 2023, featuring insights from - GSK, Accord Healthcare, Boehringer Ingelheim, CSL Behring, and the Council of Europe   

Omnichannel: Getting it right

Joseph Constance, (Feb 2, 2024)

Success with omnichannel depends on having the right customer data, analytics, and software.
Patients and Medical

How to synthesise real-world evidence and AI to transform patient-driven healthcare

Joseph Constance, (Feb 2, 2024)

Pharmaceutical companies have more real-world data (RWD) than ever

Omnichannel strategy: a valuable data source for customer profile generation

Anonymous (not verified), (Jan 12, 2024)

An omnichannel approach allows pharma companies to meet customer needs in a targeted way according to any customer’s preferred communication medium.